|
|
||||||||
1 Departments of Physiology and Medicine, Lawson Health Research Institute, University of Western Ontario, London, Ontario, Canada N6A 4V2; 2 Division of Pulmonary and Critical Care, Department of Medicine, University of Cincinnati, Cincinnati, 45267; and 3 Division of Pulmonary Biology, Children's Hospital Medical Center, Cincinnati, Ohio 45229
Surfactant alterations, alveolar cytokine changes, and the role of surfactant protein (SP)-A in septic mice were investigated. Sepsis was induced via cecal ligation and perforation (CLP). Septic and sham mice were euthanized at 0, 3, 6, 9, 12, 15, and 18 h after surgery. Mice deficient in SP-A and mice that overexpressed SP-A were euthanized 18 h after surgery. In wild-type, sham-operated mice, surfactant pool sizes were similar at all time points, whereas in the CLP groups there was a significant decrease in small-aggregate surfactant pool sizes beginning 6 h after CLP. Interleukin-6 concentrations in bronchoalveolar lavage fluid from septic animals increased from 6 to 18 h after surgery. Identical surfactant alterations and concentrations of cytokines were observed in septic mice that were SP-A deficient or that overexpressed SP-A. In conclusion, alterations of pulmonary surfactant and alveolar cytokines occur simultaneously, 6 h after a systemic insult. In addition, we did not detect a role for SP-A in regulating surfactant phospholipid pool sizes or pulmonary inflammation in septic mice.
cecal ligation and perforation; surfactant aggregates; cytokines; in vivo; mouse
This article has been cited by other articles:
![]() |
W. Huang, L. A. McCaig, R. A. W. Veldhuizen, L-J. Yao, and J. F. Lewis Mechanisms responsible for surfactant changes in sepsis-induced lung injury Eur. Respir. J., December 1, 2005; 26(6): 1074 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Martin, B. Z. Moyer, M. C. Pape, B. Starcher, K. J. Leco, and R. A. W. Veldhuizen Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis Am J Physiol Lung Cell Mol Physiol, December 1, 2003; 285(6): L1222 - L1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. P. A. Rasaiah, J. L. Malloy, J. F. Lewis, and R. A. W. Veldhuizen Early surfactant administration protects against lung dysfunction in a mouse model of ARDS Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L783 - L790. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Guillot, V. Balloy, F. X. McCormack, D. T. Golenbock, M. Chignard, and M. Si-Tahar Cutting Edge: The Immunostimulatory Activity of the Lung Surfactant Protein-A Involves Toll-Like Receptor 4 J. Immunol., June 15, 2002; 168(12): 5989 - 5992. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |